GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
Q0243
Injection, casirivimab and imdevimab, 2400 mg
HCPCS code
Similar Codes
ICD10CM codes
T80.90XA
- Unspecified complication following infusion and therapeutic injection, initial encounter
T80.90XD
- Unspecified complication following infusion and therapeutic injection, subsequent encounter
Z29.13
- Encounter for prophylactic Rho(D) immune globulin
T80.90
- Unspecified complication following infusion and therapeutic injection
Z29.1
- Encounter for prophylactic immunotherapy
T80.90XS
- Unspecified complication following infusion and therapeutic injection, sequela
Y64.1
- Contaminated medical or biological substance, injected or used for immunization
T80.2
- Infections following infusion, transfusion and therapeutic injection
T80.9
- Unspecified complication following infusion, transfusion and therapeutic injection
T80.9XXA
- Unspecified complication following infusion, transfusion and therapeutic injection, initial encounte
HCPCS codes
Q0243
- Injection, casirivimab and imdevimab, 2400 mg
Q0244
- Injection, casirivimab and imdevimab, 1200 mg
Q0245
- Injection, bamlanivimab and etesevimab, 2100 mg
Q0239
- Injection, bamlanivimab, 700 mg
C9044
- Injection, cemiplimab-rwlc, 1 mg
J9119
- Injection, cemiplimab-rwlc, 1 mg
J9228
- Injection, ipilimumab, 1 mg
M0243
- intravenous infusion, casirivimab and imdevimab includes infusion and post administration monitoring
J3380
- Injection, vedolizumab, 1 mg
J0740
- Injection, cidofovir, 375 mg
CPT4 codes
90284
- Immune globulin (SCIg), human, for use in subcutaneous infusions, 100 mg, each
90281
- Immune globulin (Ig), human, for intramuscular use
80280
- Vedolizumab
90396
- Varicella-zoster immune globulin, human, for intramuscular use
90378
- Respiratory syncytial virus, monoclonal antibody, recombinant, for intramuscular use, 50 mg, each
90687
- Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use
80230
- Infliximab
90688
- Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use
90685
- Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for in
90399
- Unlisted immune globulin